DGX
Quest Diagnostics IncNYSEResearch view
Healthcare · Services-Medical Laboratories · Large-cap · SEC EDGAR FY 2025-12-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Market Cap$27.2B
Enterprise Value$33.0B
Income$992.0M
Sales$11.0B
Book/sh$65.29
Cash/sh$3.81
Dividend TTM$1.80
Payout36%
Employees—
IPO—
Quick Ratio0.96
Current Ratio1.04
Debt/Eq0.86
EPS (ttm)$8.75
EPS this Y13.8%
EPS past 3/5Y3.2%
Sales past 3/5Y3.7%
EPS Y/Y TTM13.8%
Sales Y/Y TTM11.8%
Shs Outstand110.37M
ROA6.1%
ROE13.8%
ROIC9.1%
Gross Margin—
Oper. Margin14.1%
Profit Margin9.0%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$10.8B
2021
$9.9B
2022
$9.3B
2023
$9.9B
2024
$11.0B
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $10.8B | $9.9B | $9.3B | $9.9B | $11.0B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $2.4B | $1.4B | $1.3B | $1.3B | $1.6B |
| Net Income | $2.0B | $946.0M | $854.0M | $871.0M | $992.0M |
| Diluted EPS | $15.55 | $7.97 | $7.49 | $7.69 | $8.75 |
| Operating Cash Flow | $2.2B | $1.7B | $1.3B | $1.3B | $1.9B |
| Free Cash Flow | $1.8B | $1.3B | $864.0M | $909.0M | $1.4B |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Capital-light: capex is $527.0M against $1.9B operating cash
COMMUNITY · $DGX0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Services-Medical Laboratories
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.